RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Career Considerations: Generic vs. Innovator Pharmaceutical Regulatory Affairs

Career Considerations: Generic vs. Innovator Pharmaceutical Regulatory Affairs

Posted 01 April 2009 | By

A regulatory career can be highly rewarding for a variety of reasons, including one's involvement in the delivery of exciting healthcare products to patients in need and exposure to numerous aspects of the product development cycle. The wide array of career paths within and across the profession makes this key function that much more gratifying, especially for someone considering a change in focus within regulatory affairs. There are some factors worth considering when determining the next steps in a regulatory career. To illustrate some of these considerations, this article focuses on basic similarities and differences between regulatory roles in generic and innovator pharmaceutical firms.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.